...
机译:基于寡核 - 转移性肺病的立体定向体放射治疗的载体载体
Univ Zurich Dept Radiat Oncol Univ Zurich Hosp Zurich Switzerland;
Univ Hosp Heidelberg Dept Radiat Oncol Heidelberg Germany;
Univ Turin Dept Oncol Turin Italy;
Aarhus Univ Hosp Dept Oncol Aarhus Denmark;
Univ Hosp Heidelberg Dept Radiat Oncol Heidelberg Germany;
Univ Hosp Heidelberg Dept Radiat Oncol Freiburg Germany;
Univ Zurich Dept Radiat Oncol Univ Zurich Hosp Zurich Switzerland;
UKSH Univ Klin Schleswig Holstein Dept Radiat Oncol Kiel Germany;
Heidelberg Univ Univ Med Ctr Mannheim Dept Radiat Oncol Heidelberg Germany;
Tech Univ Munich Dept Radiat Oncol Munich Germany;
Univ Hosp Aachen Dept Radiat Oncol Aachen Germany;
Univ Hosp Munster Dept Radiat Oncol Munster Germany;
Univ Hosp Wuerzburg Dept Radiat Oncol Wurzburg Germany;
11 Ludwig Maximilians Univ Dept Radiat Oncol Munich Germany;
Univ Hosp Magdeburg Dept Radiat Oncol Magdeburg Germany;
Med Sch Hannover Dept Radiotherapy &
Special Oncol Hannover Germany;
Univ Rostock Dept Radiat Oncol Rostock Germany;
Univ Hosp Frankfurt Dept Radiat Oncol Frankfurt Germany;
Bern Univ Hosp Dept Radiat Oncol Bern Switzerland;
Helios Klinikum Berlin Buch Dept Radiat Oncol Berlin Germany;
Tech Univ Dresden Dept Radiat Oncol Fac Med Dresden Germany;
Univ Hosp Hamburg Dept Radiat Oncol Hamburg Germany;
Hosp Heidenheim Dept Radiat Oncol Heidenheim Germany;
Univ Hosp Jena Dept Radiat Oncol Jena Germany;
Philipps Univ Marburg Univ Hosp Giessen &
Marburg Dept Radiotherapy &
Radiat Oncol Marburg;
Aarhus Univ Hosp Danish Ctr Particle Therapy Aarhus Denmark;
Univ Turin Dept Oncol Turin Italy;
Univ Hosp Heidelberg Dept Radiat Oncol Heidelberg Germany;
Univ Zurich Dept Radiat Oncol Univ Zurich Hosp Zurich Switzerland;
Oligo-metastasis; Stereotactic body radiotherapy; Nomogram; Overall survival;
机译:基于寡核 - 转移性肺病的立体定向体放射治疗的载体载体
机译:用于预测阶段患者疾病进展的载体进展,其用立体定向体放射治疗的非小细胞肺癌
机译:寡聚转移性肝病的立体定向体放射治疗 - 预治疗化疗和组织学对局部肿瘤控制的影响
机译:用于在立体定向肺体放疗中基于肿瘤的患者定位的kV-CBCT图像中评估肺肿瘤位置的自动化框架
机译:Tomotherapy对呼吸运动矫正立体定向放疗患者肿瘤定位的评估
机译:诺模图的开发和外部验证可预测立体定向放疗后早期肺癌的总体生存情况
机译:P1.17-11载体预测初期丧失放射治疗早期非小细胞肺癌的整体生存效益